Patent Assignment
Reel/Frame 019255/0657
Merger
Recorded: 2007-05-07
Pages: 5
Assignor
SERENIX PHARMACEUTICALS, LLC.
Executed: 2005-07-07
Assignee
AZEVAN PHARMACEUTICALS, INC.
115 RESEARCH DRIVE, BETHLEHEM, PENNSYLVANIA, 18015
Covered Property
(1)
Beta-Lactamyl Vasopressin V1A Antagonists
Related Assignments
(4)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
May 7, 2007
From: GUILLON, CHRISTOPHE D.G.; HEINDEL, NED D.; LU, SHIFANG; SIMON, NEAL G.
To: SERENIX PHARMACEUTICALS, LLC.
Reel/Frame 019255/0636 →
Corrective Assignment to Correct the Assignors Lu and Simon Should Not Have Been Identified. Document Dates for Each Remaining Assignor Need to Be Corrected as Well. Previously Recorded on Reel 019255 Frame 636. Assignor(S) Hereby Confirms the Assignment of Assignor's Interest.
May 8, 2007
From: BRUNS, ROBERT F., JR; GUILLON, CHRISTOPHE D.G.; HEINDEL, NED D.; KOPPEL, GARY A.
To: SERENIX PHARMACEUTICALS, LLC.
Reel/Frame 019262/0274 →
Confirmatory License
Jun 11, 2008
From: AZEVAN PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 021078/0602 →
Confirmatory License
Jan 6, 2017
From: AZEVAN PHARMACEUTICALS, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 041273/0157 →